Drugs / N,N-dimethyltryptamine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05780216 | Feb → Aug 2023 | — | Milan Scheidegger | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | N,N-dimethyltryptamine | “The intervention used in this study is a combination of the two main ingredients of ayahuasca, DMT (N,N-dimethyltryptamine) and harmine in purified form.” NCT05780216 ↗ |
| Known as | DMT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05780216 ↗ |